| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 26.10. | Sutter Health Expands Remote Monitoring Program to Patients with Heart Failure | ||
| 26.10. | In a Maternity Care Crisis, CMS Undermines Efforts To Modernize Care | ||
| 26.10. | FDA Alignment Is a Starting Point, Not a Rare Disease Strategy for the European Market | ||
| 26.10. | CareValidate Launches Expanded HRT Offering | ||
| 25.10. | Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science | ||
| 25.10. | Congress's Patient Matching Fix Won't Work - Here's What Would | ||
| 25.10. | Physician Mental Health and Health System Privacy: Why Doctors Avoid Their Own EHR | ||
| 25.10. | Fractyl's Weight Maintenance Device Meets Clinical Goal, but Shares Nosedive, Layoffs Follow | ||
| 23.10. | Where Are the Biggest Opportunities in Women's Cardiovascular Health? | ||
| 23.10. | Gilead to Pay $1.3B for Oral Peptide That Could Rival J&J's New Immunology Pill | ||
| 23.10. | Why an Independent NP Practice Requires an Undergraduate Business Foundation | ||
| 23.10. | Amazon, Google and Other Major Employers Back CMS Prior Auth Effort | ||
| 22.10. | Alcon Expands Its Cell Therapy Ambitions With $550M Neurotech Pharma Acquisition | ||
| 22.10. | Why SDoH Programs Fall Short - and What It Takes to Make Them Work | ||
| 22.10. | INVEST Digital Health Celebrates Healthcare Innovation in Texas | ||
| 22.10. | Judi Health Launches Medicare Part D Plan for Employers | ||
| 21.10. | GSK Wins FDA Nod for Novel Hepatitis B Drug Offering a Potential Functional Cure | ||
| 21.10. | AMA Calls for Risk-Based GenAI Oversight to Protect Patients and Support Responsible Innovation | ||
| 21.10. | Your Product Works - So Why Does It Still Fail in the Real World? | ||
| 21.10. | FDA Official Believes GenAI-enabled Tools Will Need to Be Assessed Like a Physician | ||
| 20.10. | Readily Secures $11M for Compliance Intelligence Platform | ||
| 20.10. | GSK Immunotherapy Gets Accelerated FDA Approval for Treating Rectal Cancer | ||
| 20.10. | A Radical Proposal to Preserve Cell and Gene Therapy Innovation | ||
| 20.10. | Report: Health System M&A Activity Remains Steady in Third Quarter | ||
| 20.10. | AdvaMed's 4 Policy Priorities, According to Its CEO |